Menu
Enrolling by invitation NCT06793293

Postoperative in Cesarean Section, the Women Suffering from Pain Due to Wound "incisional Pain", High Level Laser One of Most Effective Methods That Promoting Healing and Decrease Pain so It Will Effective If Use in Decreasing Pain of Cesarian Section

No phase Interventional Cesarean Section Pain

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: High level laser, Non-steroidal anti- inflammatory drugs and antibiotics.
Who it may be relevant to
Registry conditions: Cesarean Section Pain. Basic parameters: 20 years — 40 years · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Egypt
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Effect of High Level Laser Therapy on Postoperative Cesarean Section Incisional Pain

Overview

High power laser is safe and effective methods, it's uses increasing one day after day in decreasing pain and promoting healing so its use in postoperative cesarian section will help mothers to overcome pain and return to ADLs faster

Interventions

  • Device High level laser
    It will be consisted of twenty-five postoperative cesarean section women and will be treated by medical treatment (Non-steroidal anti- inflammatory drugs and antibiotics) in addition to High level laser for 5 minutes on days 1 st , 2 nd , and 3 rd , after cesarean section (3 sessions)
  • Drug Non-steroidal anti- inflammatory drugs and antibiotics
    It will be consisted of twenty-five postoperative cesarean section women and will be treated by medical treatment (Non-steroidal anti- inflammatory drugs and antibiotics) only.

Primary outcome measures

  • Visual analog scale (VAS): [Time frame: third day]
  • Blood test [Time frame: third day]

Eligibility criteria

Inclusion criteria

  • Their ages will be ranged from 20-40 years. 2. Their BMI will be less than 30 Kg\\m 2 3. Patients with lower segment cesarean section (Poursalehan et al., 2018 \& de Holanda et al., 2020).

Exclusion criteria

  • 1\. Patients with upper segment cesarean section. 2. Diabetic patient. 3. Patient with malignancy, benign tumors with the possibility to become malignant. 4. Infection of the skin (Poursalehan et al., 2018).

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Treatment

Study locations

Egypt · 1 center
  • Cairo university — Cairo

Identifiers

NCT: NCT06793293 · P.T.Rec/012/005570

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗